Retention of unmethylated CpG island alleles in human diploid fibroblast x fibrosarcoma hybrids expressing high levels of DNA methyltransferase

Cell Growth and Differentiation

Volumn 7, Issue 6, 1996, Pages 847-853

  Kuerbitz, Steven J ^a,b   Baylin, Stephen B ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA METHYLTRANSFERASE;

ARTICLE; CANCER CELL; CELL LINE; DNA METHYLATION; FIBROBLAST; FIBROSARCOMA; GENE EXPRESSION; HUMAN; HUMAN CELL; HYBRID CELL; PRIORITY JOURNAL;

ALLELES; BASE COMPOSITION; CELL LINE; DIPLOIDY; DNA METHYLATION; DNA MODIFICATION METHYLASES; FIBROBLASTS; FIBROSARCOMA; HUMANS; HYBRID CELLS; TUMOR CELLS, CULTURED;

EID: 0029827327     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Gartler, S. M., and Riggs, A. D. Mammalian X-chromosome inactivation. Annu. Rev. Genet., 17: 155-190, 1983.
2. Wolf, S. F., Jolly, D. J., Lunnen, K. D., Friedmann, T., and Migeon, B. R. Methylation of the hypoxanthine phosphoribosyltransferase locus on the human X chromosome: implications for X-chromosome inactivation. Proc. Natl. Acad. Sci. USA, 81: 2806-2810, 1984.
3. Bartolomei, M. S., Weber, A. L., Brunkow, M. E., and Tilghman, S. M. Epigenetic mechanisms underlying the imprinting of the mouse H19 gene. Genes & Dev., 7: 1663-1673, 1993.
4. Stöger, R., Kubicka, P, Liu, C-G., Kafri, T., Razin, A., Cedar, H., and Barlow, D. P. Maternal-specific methylation of the imprinted mouse lgf2R locus identifies the expressed locus as carrying the imprinting signal. Cell, 73: 61-71, 1993.
5. De Bustros, A., Nelkin, B. D., Silverman, A., Ehrlich, G., Poiesz, B., and Baylin, S. B. The short arm of chromosome 11 is a "hot spot" for hypermethylation in human neoplasm. Proc. Natl. Acad. Sci. USA, 85: 5693-5697, 1988.
6. Makos, M., Nelkin, B. D., Lerman, M. I., Latif, F., Zbar, B., and Baylin. S. B. Distinct hypermethylation patterns occur at altered chromosome loci in human lung and colon cancer. Proc. Natl. Acad. Sci. USA, 69: 1929-1933, 1992.
7. Nelkin, B. D., Przepiorka, D., Burke, P. J., Thomas, E. D., and Baylin, S. B. Abnormal methylation of the calcitonin gene marks progression of chronic myelogenous leukemia. Blood, 77: 2431-2434, 1991.
8. Antequera, F., Boyes, J., and Bird, A. High levels of de novo methylation and altered chromatin structure at CpG islands in cell lines. Cell, 62: 503-514, 1990.
9. Levine, A., Cantoni, G. L., and Rhazin, A. Inhibition of promoter activity by methylation: possible involvement of protein mediators. Proc. Natl. Acad. Sci. USA, 89: 10119-10123, 1992.
10. Boyes, J., and Bird, A. DNA methylation inhibits transcription indirectly via a methyl-CpG binding protein. EMBO J., 11: 327-333, 1992.
11. Thompson, J. P., Simkevich, C. P., Holness, M. A., Kang, A. H., and Raghow, R. In vitro methylation of the promoter and enhancer of Proα1(I) collagen gene leads to its transcriptional inactivation. J. Biol. Chem., 266: 2549-2556, 1991.
12. Bestor, T. Activation of a mammalian DNA methyltransferase by cleavage of a Zn binding regulatory domain. EMBO J., 11: 2611-2617, 1992.
13. Herman, J. G., Latif, F., Weng, Y., Lerman, M. I., Zbar, B., Liu, S., Samid, D., Duan, D-S. R., Gnarra, J. R., Linehan, M., and Baylin, S. B. Silencing of the VHL tumor suppressor gene by DNA methylation in renal carcinoma. Proc. Natl. Acad. Sci. USA, 91: 9700-9704, 1994.
14. Sakai, T., Toguchida, J., Ohtani, N., Yandell, D. W., Rapaport, J. M., and Dryja, T. P. Allele-specific methylation of the retinoblastoma tumor-suppressor gene. Am. J. Hum. Genet., 48: 880-881, 1991.
15. Merlo, A., Herman, J. G., Mao, L., Lee, D. J., Gabrielson, E., Burger, P., Baylin, S. B., and Sidransky, D. 5′ CpG island methylation is associated with transcriptional silencing of the tumor suppressor p16/CDKN2/ MTS1 in human cancers. Nat. Med., 1: 686-692, 1995.
16. Kautiainen, T. L., and Jones, P. A. DNA methyltransferase levels in tumorigenic and nontumorigenic cells in culture. J. Biol. Chem., 261: 1594-1598, 1985.
17. Issa, J-P. J., Vertino, P. M., Wu, J., Sudha, S., Celano, P., Nelkin, B. D., Hamilton, S. R., and Baylin, S. B. Increased cytosine DNA-methyltransferase activity during colon tumor progression. J. Natl. Cancer Inst., 85: 1235-1240, 1993.
18. Wu, J., Issa, J-P., Herman, J., Bassett, D. E., Jr., Nelkin, B. D., and Baylin, S. B. Expression of an exogenous eukaryotic DNA methyltransferase gene induces transformation of NIH3T3 cells. Proc. Natl. Acad. Sci. USA, 90: 8891-8895, 1993.
19. Bestor, T. H., and Ingram, V. M. Two DNA methyltransferases from murine erythroleukemia cells: purification, sequence specificity, and mode of interaction with DNA. Proc. Natl. Acad. Sci. USA, 80: 5559-5563, 1983.
20. Benedict, W. F., Weissman, B. E., Corey, M., and Stanbridge, E. J. Tumorigenicity of human HT1080 fibrosarcoma × normal fibroblast hybrids: chromosome dosage dependency. Cancer Res., 44: 3471-3479, 1984.
21. Gardiner-Gardiner, M., and Frommer, M. CpG islands in vertebrate genomes. J. Mol. Biol., 196: 261-282, 1987.
22. Ledbetter, D. H., Ledbetter, S. A., vanTuinen, P., Summers, K. M., Robinson, T. J., Nakamura, Y., Wolff, R., White, R., Barker, D. F., Wallace, M. R., Collins, F. R., and Dobbins, W. B. Molecular dissection of a contiguous gene syndrome: frequent submicroscopic deletions, evolutionarily conserved sequences, and a hypomethylated "island" in the Miller-Dieker chromosome region. Proc. Natl. Acad. Sci. USA, 86: 5136-5140, 1989.
23. Makos, M., Nelkin, B. D., Chazin, V. R., Cavenee, W. K., Brodeur, G. M., and Baylin, S. B. DNA hypermethylation is associated with 17p allelic loss in neural tumors. Cancer Res., 53: 2715-2718, 1993.
24. Makos, M., Nelkin, B. D., Reiter, R. E., Gnarra, J. R., Brooks, J., Isaacs, W., Linehan, M., and Baylin, S. B. Regional DNA hypermethylation at D17S5 precedes 17p structural changes in the progression of renal tumors. Cancer Res., 53: 2719-2722, 1993.
25. Makos, M. M., Biel., M. A., El Diery, W., Nelkin, B. D., Issa, J-P., Cavenee, W. K., Kuerbitz, S. J., and Baylin, S. B. p53 activates expression of HIC-1, a new candidate tumor suppressor gene on 17p13.3. Nat. Med., 1: 570-577, 1995.
26. Issa, J-P. J., Ottaviano, Y. L., Celano, P., Hamilton, S. R., Davidson, N. E., and Baylin, S. B. Methylation of the oestrogen receptor CpG island links aging and neoplasia in human colon. Nat. Genet., 7: 536-540, 1994.
27. Tlsty, T. D., White, A., and Sanchez, J. Suppression of gene amplification in human cell hybrids. Science (Washington DC), 255: 1425-1427, 1992.
28. Vertino, P. M., Issa, J-P., Pereira-Smith, O. M., and Baylin, S. B. Stabilization of DNA methyltransferase levels and CpG island methylation precede SV40-induced immortalization of human fibroblasts. Cell Growth & Differ., 5: 1395-1402, 1994.
29. Wilson, V. L., and Jones, P. A. DNA methylation decreases in aging but not in immortal cells. Science (Washington DC), 220: 1055-1057, 1983.
30. Matsumura, T., Hunter, J. L., Farooq, M., and Holliday, R. Maintenance of DNA methylation levels in SV40-infected cells during their in vitro limited life span. Exp. Cell Res., 184: 148-157, 1989.
31. Mummaneni, P., Bishop, P. L., and Turker, M. S. A cis-acting element accounts for a conserved methylation pattern upstream of the mouse adenine phosphoribosyltransferase gene. J. Biol. Chem., 268: 552-558, 1993.
32. Macleod, D., Charlton, J., Mullins, J., and Bird, A. P. Sp1 sites in the mouse aprt gene promoter are required to prevent methylation of the CpG island. Genes & Dev., 8: 2282-2292, 1994.
33. Brandeis, M., Frank, D., Keshet, I., Seigfreid, Z, Mendelsohn, M., Nemes, A., Temper, V., Razin, A., and Cedar, H. Sp1 elements protect a CpG island from de novo methylation. Nature (Lond.), 371: 435-438, 1994.
34. Mummaneni, P., Walker, K. A., Bishop, P. L., and Turker, M. S. Epigenetic gene inactivation induced by a cis-acting methylation center. J. Biol. Chem., 270: 788-792, 1995.
35. Verkerk, A. J. M. H., Pieretti, M., Sutcliffe, J. S., Fu, Y-H., Kuhl, D. P. A., Pizzuti, A., Reiner, O., Richards, S., Victoria, M. F., Zhang, F., Eussen, B. E., van Ommen, G-J. B., Blonden, L. J., Riggins, G. J., Chastain, J. L., Kunst, C. B., Galijaard, H., Caskey, C. T., Nelson, D. L., Oostra, B. A., and Warren, S. T. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell, 65: 905-914, 1991.
36. Knight, S. J. L., Flannery, A. V., Hirst, M. C., Campbell, L., Christodoulou, Z., Phelps, S. R., Pointon, J., Middleton-Price, H. R., Barnicoat, A., Pembrey, M. E., Holland, J., Oostra, B. A., Bobrow, M., and Davies, K. E. Trinucleotide repeat amplification and hypermethylation of a CpG island in FRAXE mental retardation. Cell, 74: 127-134, 1993.
37. Parrish, J. E., Oostra, B. A., Verkerk, A. J. M. H., Richards, C. S., Reynolds, J., Spikes, A. S., Shaffer, L. G., and Nelson, D. L. Isolation of a GCC repeat showing expansion in FRAXF, a fragile site distal to FRAXA and FRAXE. Nat. Genet., 8: 229-235, 1994.
38. Nancarrow, J. K., Kremer, E., Holman, K., Eyre, H., Doggett, N. A., Le Paslier, D., Callen, D. F., Sutherland, G. R., and Richards, R. I. Implication of FRA16A structure for the mechanism of chromosomal fragile site genesis. Science (Washington DC), 264: 1938-1941, 1994.
39. Hubbard-Smith, K., Patsalis, P., Pardinas, J. R., Jha, K. K., Henderson, A. S., and Ozer, H. L. Altered chromosome 6 in immortal human fibroblasts. Mol. Cell. Biol., 12: 2237-2281, 1992.
40. Westerhausen, A., Kishi, J., and Prockop, D. J. Mutations that substitute serine for glycine α1-598 and glycine α1-631 in type I procollagen. J. Biol. Chem., 265: 13995-14000, 1990.
41. Ball, D. W., Compton, D., Nelkin, B. D., Baylin, S. B., and de Bustros, A. Human calcitonin gene regulation by helix-loop-helix recognition signals. Nucleic Acids Res., 20: 117-123, 1992.